To determine the therapeutic potential of Wee1 inhibitor-cisplatin combination against GC in vitro, a series of GC cell lines as indicated were treated with a widely used Wee1 inhibitor AZD1775 in the absence or presence of cisplatin. Here, WEE1 is linked to gastric cancer.